Som forventet steg antallet af anmodninger om inspektioner med relation til god klinisk praksis (GCP) for humanmedicinske lægemidler i 2002 til trods for, at antallet af centraliserede ansøgninger var lavere end anslået.
Three GMP workshops were held as part of the PERF II programme, as well as joint inspections in the accession candidate countries.